SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
Islamic State group militants claim capture and execution of a Nigerian brigadier general - 2Stop the ‘good’ vs ‘bad’ snap judgments and watch your world become more interesting
- 375% of US adults may meet criteria for obesity under new definition, study finds
- 4Most loved Web-based feature: Which Stage Do You Like
- 5Virtual reality opens doors for older people to build closer connections in real life
- How to disinfect if the stomach bug hits your home
- Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere
- Voting begins in Uganda’s presidential election during internet shutdown and polling station delays
- Find the Effect of Web-based Entertainment on Society: Exploring the Computerized Scene
- A definitive Manual for Picking Electric Vehicle: Decision in favor of Your Number one
- Language Learning Stages: Which One Gets Your Vote?
- What to know about MIT professor Nuno Loureiro and the investigation into his shooting
- 5 Fundamental Ways to employ a Criminal Legal counselor
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
